Industry

Could the statistical phenomenon of regression to the mean be responsible for the dramatic effects of placebo—as well as the supposed effectiveness of some psychiatric drugs?

Interviews with psychosocially oriented psychologists demonstrate their experiences of discomfort with the hegemony of the medical model in their place of work and the conflicts that arise when they attempt to provide alternatives.

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

Neuroscience researchers find no differences in brain connectivity between children with diagnoses of autism, ADHD, and those with no diagnoses.

Twice as many teenagers with ADHD experienced severe psychosis when taking Adderall, as compared to Ritalin, according to a new study.

A new study investigated whether participants guessing if they have an antidepressant or placebo affects response rates.

The candidate-gene approach to depression goes unsupported and is likely based on bad science, new research finds.

Dr. Gail Hornstein, author of Agnes’s Jacket: A Psychologist’s Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.

The latest issue of the journal Behavioral and Brain Sciences features several prominent researchers arguing that mental health concerns are not “brain disorders.”

Researchers examine psychiatrist-client interactions and find that clients are often left with few opportunities to make explicit requests to change their medication regimen.

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

CBT forwards a hyper-rational perspective of human suffering that complements a managerialist culture of efficiency and institutionalization in the Western world.

A new study examines the effects of CBD as an adjunct therapy to antipsychotic medication for patients diagnosed with schizophrenia.

“Converging lines of evidence now suggest that depression—a common comorbidity in the setting of chronic pain—may in some patients represent an unrecognized yet potentially reversible harm of opioid therapy.”

Researchers question the overstated results of a large antidepressant meta-analysis and point to cultural pressures to turn to these drugs for a quick fix.

John Ioannidis, a leading expert on research methods, takes a critical look at the way professional societies write treatment guidelines.

Climate change-related extreme weather and increasing temperatures associated with higher rates of mental health challenges.

Dr. Dainius Pūras argues that the status quo in mental health treatment is no longer acceptable and demands political action to promote human rights.

A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.

In an effort to reduce coercion, researchers isolate associated factors including age, relationship status, location, and diagnosis.

Researchers outline the concept of ecologically driven grief due to climate change and recommend future research to better understand the psychological impact of climate change.

Researchers challenge the recommendation of starting two antidepressants simultaneously to increase preventative effects against suicide.

Historical, current, and potential future complexities of cognitive assessment; a longstanding, controversial fixture in schools throughout the United States.

A new study has found that children and adolescents taking a high dose of antipsychotics are almost twice as likely to die of any cause than children on other types of medications.

Researchers detect a striking relationship between the month of school enrollment relative to peers and patterns of ADHD diagnoses in a large sample of elementary school students throughout the US.